Know Cancer

or
forgot password

    • cancer clinical trials in chesterfield, MO

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer
    Evaluation of Stool Tagging for Improved Patient Compliance
    Diagnostic Imaging Associates
    Chesterfield, Missouri 63017
    Colon Cancer, Polyps
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Breast Cancer, Breast Neoplasms
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Non-Small Cell Lung Cancer
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Non-Small Cell Lung Cancer
    Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Mantle Cell Lymphoma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Renal Cell Carcinoma
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Breast Cancer
    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Glioblastoma Multiforme
    Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Breast Cancer
    Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Metastatic Breast Cancer
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    Chesterfield, Missouri 63017
    Diffuse Large B-Cell Lymphoma
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Advanced Renal Cell Carcinoma
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Bone Metastases
    Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Breast Cancer
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer, Cardiac Toxicity
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Colorectal Cancer, Precancerous Condition
    Connect® MM- The Multiple Myeloma Disease Registry
    St. Louis Cancer Care, LLP
    Chesterfield, Missouri 63017
    Multiple Myeloma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer
    Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Kidney Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Grade IV Glioma, Grade IV Astrocytoma, Glioblastoma Multiforme
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    St. Louis Cancer Care, LLP
    Chesterfield, Missouri 63017
    Advanced Prostate Cancer, Prostatic Neoplasms
    Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Glioblastoma Multiforme
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    St. Louis Cancer Care, LLP
    Chesterfield, Missouri 63017
    Prostate Cancer
    A Retrospective Cohort Study of Infusion Reactions Due to Vectibix
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Infusion Reaction
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Melanoma (Skin)
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer, Osteoporosis
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Non Small Cell Lung Carcinoma
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Multiple Sclerosis, Relapsing-Remitting
    RAD001 Plus Bevacizumab in Metastatic Melanoma
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Metastatic Melanoma
    Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Breast Cancer
    Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer
    St. Louis Cancer Care
    Chesterfield, Missouri 63017
    Small Cell Lung Cancer
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    St. Louis Cancer Care, LLP
    Chesterfield, Missouri 63017
    Relapsed Follicular Lymphoma
    Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Glioma, High Grade Astrocytoma, Glioblastoma Multiforme
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Saint Luke's Hospital
    Chesterfield, Missouri 63017
    Breast Cancer